• LINC02870 Drives SNAIL Translation and HCC Progression via E

  2026-05-10

  This study identifies LINC02870 as an oncogenic lncRNA in hepatocellular carcinoma (HCC), demonstrating its role in enhancing SNAIL translation through interaction with EIF4G1. The findings have implications for understanding HCC metastasis mechanisms and highlight molecular targets for future therapeutic strategies.

• Revisiting Sumatriptan Metabolism: Roles of MAO A and CYP Is

  2026-05-09

  This article reviews a recent study that re-examines the metabolic pathways of sumatriptan, a migraine medication, highlighting the unexpected involvement of cytochrome P450 enzymes alongside monoamine oxidase A. The findings have implications for understanding drug metabolism mechanisms relevant to neuropharmacology and modeling in neurodegenerative disease research.

• Radicicol in Systems Biology: Beyond Hsp90 to Inflammation M

  2026-05-09

  Explore Radicicol as a potent Hsp90 inhibitor with unique anti-inflammatory and apoptosis-enhancing actions. This article reveals deeper systems biology applications, bridging mitochondrial dysfunction and inflammation pathways, and offers advanced assay guidance.

• (+)-Bicuculline: Protocol Parameters and Workflow Guidance

  2026-05-08

  (+)-Bicuculline is a classical GABAA receptor antagonist used for dissecting inhibitory neurotransmission and synaptic signaling in controlled neuroscience studies. Its application is limited to research use, requiring strict adherence to preparation and storage protocols for reproducible results. It is not suitable for diagnostic or clinical applications.

• Real-World Applications of O-propargyl-puromycin (OPP) in Pr

  2026-05-07

  This article addresses laboratory challenges in measuring protein synthesis and cellular responses, focusing on the application of O-propargyl-puromycin (OPP, SKU A8778). Drawing from peer-reviewed research and practical protocol insights, it demonstrates how OPP delivers reproducibility and sensitivity for cell viability, proliferation, and cytotoxicity assays.

• EdU Flow Cytometry Assay Kits (Cy3): Advanced S-Phase Detect

  2026-05-07

  EdU Flow Cytometry Assay Kits (Cy3) from APExBIO empower researchers to quantify cell proliferation with high sensitivity and minimal workflow disruption. Their click chemistry–based platform outperforms legacy BrdU assays, making them indispensable for advanced cell cycle, genotoxicity, and pharmacodynamic studies.

• Telomere Recapping Restores Cardiac-Mitochondrial Balance in

  2026-05-06

  This study demonstrates that telomere recapping via a modified telomerase protein halts detrimental telomere-to-mitochondrial DNA signaling in heart failure. The findings establish a mechanistic link between telomere deprotection, p53 activation, and mitochondrial dysfunction, providing a foundation for telomere-targeted gene therapy approaches to cardiac disease.

• Ciprofloxacin Potentiates Ferroptosis via Mitochondrial Zinc

  2026-05-06

  This study uncovers how ciprofloxacin, beyond its antimicrobial use, enhances RSL3-induced ferroptosis in cancer cells through mitochondrial zinc accumulation mediated by the STING1–CAV2 pathway. The findings clarify the dual role of ciprofloxacin in ferroptosis regulation and highlight new mechanistic links between antibiotic action, zinc homeostasis, and regulated cell death, informing therapeutic strategies in oncology.

• CH 223191 in Translational Research: Mechanisms, Impact, and

  2026-05-05

  Explore how CH 223191, a potent aryl hydrocarbon receptor antagonist from APExBIO, drives mechanistic insight and strategic innovation in translational research. Learn how this tool compound enables rigorous dissection of dioxin toxicity mechanisms, facilitates advanced modeling of AhR signaling pathways, and inspires next-generation therapeutic strategies, particularly in light of emerging microbiota–tryptophan–AhR axis research. This article bridges validated experimental protocols with future-facing translational opportunities, providing actionable guidance for researchers seeking to unravel environmental toxicology and regenerative medicine frontiers.

• AICAR: AMPK Activation for Energy Metabolism & Inflammation

  2026-05-05

  AICAR (5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside) is a cell-permeable AMPK activator widely used in energy metabolism and inflammation research. Its rapid activation, high solubility in DMSO and water, and reproducible modulation of metabolic pathways make it a gold standard for dissecting cellular responses to metabolic stress. Benchmarks confirm its efficacy and versatility across in vitro and in vivo models.

• Decitabine (5-Aza-2'-deoxycytidine): Toxicology, Mechanisms,

  2026-05-04

  Explore the advanced toxicological profile and mechanistic insights of Decitabine (5-Aza-2'-deoxycytidine) for cancer epigenetics research. This article uniquely bridges foundational toxicology with practical assay optimization, offering a deeper perspective for translational oncology applications.

• Structural Insights into HCAR3 Selectivity via Acifran Compl

  2026-05-04

  Ye et al. resolve the cryo-EM structures of HCAR3 in complex with selective agonists, including Acifran, elucidating the molecular determinants of ligand recognition and selectivity. These findings provide a structural framework for rational design of hypolipidemic agents targeting lipid metabolism with improved specificity and reduced side effects.

• 4-Phenylbutyric Acid: Precision Modulation of ER Stress Path

  2026-05-03

  Explore the advanced role of 4-Phenylbutyric acid in ER stress pathway modulation and its unique utility for apoptosis and autophagy research. This in-depth analysis highlights new mechanistic insights and practical assay guidance.

• Sulfaphenazole: Translational Leverage in Vascular Research

  2026-05-02

  This thought-leadership article explores Sulfaphenazole's mechanistic role as a selective CYP2C9 inhibitor in vascular endothelial function restoration, emphasizing its translational potential for diabetic vascular dysfunction. Integrating evidence from foundational studies and advanced content resources, it delivers actionable protocol guidance and a strategic outlook for translational researchers. The article further distinguishes itself by dissecting Sulfaphenazole's impact beyond common product narratives, connecting oxidative stress modulation with drug metabolism and vascular repair.

• ABT-199 (Venetoclax): Precision Bcl-2 Inhibition in Apoptosi

  2026-05-02

  Harness the selectivity of ABT-199 (Venetoclax) to dissect mitochondrial apoptosis in hematologic malignancy and senescence models. This article delivers stepwise protocols, cross-study insights, and troubleshooting strategies for maximizing experimental impact with APExBIO’s validated compound.

455 records 19/31 page Previous Next First page 上5页 1617181920 下5页 Last page